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Abstract
Therapeutic glycoproteins have played a major role in the commercial success of biotechnology in the post-genomic era.
But isolating recombinant mammalian cell lines for large-scale production remains costly and time-consuming, due to
substantial variation and unpredictable stability of expression amongst transfected cells, requiring extensive clone
screening to identify suitable high producers. Streamlining this process is of considerable interest to industry yet the
underlying phenomena are still not well understood. Here we examine an antibody-expressing Chinese hamster ovary
(CHO) clone at single-cell resolution using flow cytometry and vectors, which couple light and heavy chain transcription to
fluorescent markers. Expression variation has traditionally been attributed to genetic heterogeneity arising from random
genomic integration of vector DNA. It follows that single cell cloning should yield a homogeneous cell population. We
show, in fact, that expression in a clone can be surprisingly heterogeneous (standard deviation 50 to 70% of the mean),
approaching the level of variation in mixed transfectant pools, and each antibody chain varies in tandem. Phenotypic
variation is fully developed within just 18 days of cloning, yet is not entirely explained by measurement noise, cell size, or
the cell cycle. By monitoring the dynamic response of subpopulations and subclones, we show that cells also undergo slow
stochastic fluctuations in expression (half-life 2 to 11 generations). Non-genetic diversity may therefore play a greater role in
clonal variation than previously thought. This also has unexpected implications for expression stability. Stochastic gene
expression noise and selection bias lead to perturbations from steady state at the time of cloning. The resulting transient
response as clones reestablish their expression distribution is not ordinarily accounted for but can contribute to declines in
median expression over timescales of up to 50 days. Noise minimization may therefore be a novel strategy to reduce
apparent expression instability and simplify cell line selection.
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Introduction
Protein biologics are an important and growing segment of the
drug industry with over US$80 billion in sales worldwide. Many
protein biologics, including monoclonal antibodies, are large,
structurally-complex glycoproteins requiring functional human-like
post-translational modifications for their in vivo activity [1]. Cultured
mammalian cells, and particularly Chinese hamster ovary (CHO)
cells [2], are generally employed as production hosts because
simpler prokaryotic and eukaryotic expression systems lack suitable
native glycosylation machinery and may not fold and secrete these
biomolecules efficiently [3]. Yet despite their widespread use and
commercial significance, two major issues remain unresolved in
establishing productive mammalian cell lines, namely clonal
heterogeneity [4] and expression instability [5].
Large-scale production of recombinant proteins relies on stable
integration of expression vectors into the host genome [6].
Ordinarily this involves non-targeted DNA delivery and chemical
selection to integrate and amplify transgene sequences encoding
the product [7]. The resulting transfectants differ markedly in
expression due to an inherent lack of control over gene dosage and
chromosomal context of integrating copies [8–10]. Random
integration and amplification may also disrupt or dysregulate
endogenous genes [11–13] creating the potential for variation in
other cell traits [14,15]. Accordingly, production cell lines are
‘cloned’, or derived from a single cell, in order to minimize
heterogeneity (International Conference on Harmonisation (ICH),
Guideline Q5D, 1997).
Upstream of the cloning step, however, the marked diversity
amongst transfectants makes the process of clone isolation a
considerable challenge. High producers are rare and those also
satisfying product quality and other selection criteria, such as rapid
growth, are rarer still [6]. Extensive empirical screening of large
numbers of candidate clones is therefore required, which is
resource intensive and frequently rate limiting in early develop-
ment. Protein expression stability also tends to be problematic.
Most clones suffer a decline in productivity during the extended
culture periods required to reach manufacturing scale, yet this is
unpredictable and varies from clone to clone. Efforts to define the
molecular determinants of stability [16] have so far achieved only
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monitoring each clone over several months of growth.
Prior examination of these issues has focused chiefly on
differences between clones isolated from mixed populations, such
as those arising from transfection or gene amplification [4,17–24].
We take an alternate approach, exploring the degree of variation
within a clone, using single cell analysis facilitated by IRES-driven
coexpression of intracellular fluorescent markers. Clones are
normally assumed to be homogeneous but emerging fundamental
research in bacteria [25–28], yeast [29–34], and more recently
mammalian cells [35–39], has revealed that gene expression can
vary significantly between genetically-identical cells, even in a
common environment (reviewed in [40,41]). We reasoned that this
‘hidden’ source of variation within clones [42,43] might also have
practical implications for cell line development, which are not yet
widely appreciated. Indeed, we show in this study that intraclonal
heterogeneity contributes materially to clonal variation and even
to the apparent instability of expression over time. This fresh
perspective may open up new avenues for understanding and
overcoming these longstanding problems.
Results
Distribution of Expression Levels in a Clonal Population
We utilized a pair of expression vectors developed for
accelerated screening of monoclonal antibody producing cell lines
by fluorescence-activated cell sorting (FACS) [44]. Each construct
encodes a human immunoglobulin G subclass 4 (IgG4) kappa light
chain or gamma heavy chain coupled to enhanced green or yellow
fluorescent protein (EGFP or EYFP) by an attenuated internal
ribosomal entry site (aIRES) (Fig. 1A). EGFP and EYFP serve as
chain-specific reporters transcribed from the same promoter and
translated proportionally but at a lower rate than the antibody
chains [45]. When co-expressed, we found intracellular reporter
fluorescence to be correlated with cell-specific antibody secretion
at the population level [44], and with ‘cold capture’ cell surface
antibody [46] at the single-cell level (Fig. S1).
A representative dual-expressing clone (5H6) was isolated from
a co-transfected gene-amplified CHO-K1 pool by FACS single cell
deposition. This clone, consistent with others we have isolated
[44], exhibited considerable cell-to-cell variation by flow cytom-
Figure 1. Expression heterogeneity in a clone. A) Bicistronic antibody expression constructs [44] designed to screen IgG4 kappa light chain (LC)
and gamma heavy chain (HC) transcription using fluorescent reporter proteins (EGFP and EYFP) translated from the same mRNA by an attenuated
encephalomyocarditis virus (EMCV) internal ribosomal entry site (aIRES). A metal-responsive promoter drives transcription (Methods). A hybrid
synthetic intron situated immediately upstream of the aIRES improves efficiency of 39 pre-mRNA processing [95]. Features other than fluorescent
proteins and immunoglobulin chains are identical between constructs. B) Bivariate distribution of reporter protein fluorescence in cells from a dual-
expressing clone (5H6, cell-specific antibody secretion rate ,2 pg/cell-day) measured by flow cytometry (main panel). Note split linear-log axes.
Spectral overlap and autofluorescence were compensated using single-color controls and untransfected cells (adjacent panels, see Methods).
Histogram counts on each axis in main panel are univariate distributions of EGFP and EYFP fluorescence in the clone, with coefficients of variation
(CV=s.d./mean) of 0.7. R
2 in main panel is for linear fit to double-positive cells (fit not shown). 10,000 events shown in each panel. Fluorescence in
arbitrary units (A.U.).
doi:10.1371/journal.pone.0008432.g001
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is not apparent in more traditional bulk assays such as ELISA
which measure only the population mean. The EGFP and EYFP
fluorescence distributions in the clone were unimodal and
qualitatively log-normal with coefficients of variation (CV=stan-
dard deviation/mean) of between 0.5 and 0.7 (depending on the
day of measurement), and signals spanning at least an order of
magnitude (Fig. 1B, main panel). Uniform calibration beads at
a similar fluorescence intensity had a CV of ,0.05, indicating
ample measurement resolution (not shown). Polyclonal gene-
amplified single color pools (Fig. 1B, adjacent panels) (and co-
transfected pools, not shown) were bimodally distributed in the
respective channels (possessing both expressing and non-express-
ing subpopulations). Surprisingly, they otherwise spanned a similar
range of fluorescence intensities to the clone, in spite of greater
genetic heterogeneity. This suggests expression variation in a clone
can be large relative to variation between clones.
Expression levels of the two transgenes were also highly
correlated when expressed together in the clone (R
2=0.926), with
points lying mainly along the diagonal in a bivariate plot (Fig. 1B,
main panel). The majority of expression noise therefore exerts
an equal influence on both transgenes, maintaining a similar ratio
of light to heavy chain transcription despite considerable cell-to-
cell variation in the expression of each chain. This was also evident
in other dual-expressing clones [44], and may be needed for
efficient antibody assembly and secretion [47]. The correlation
likely arises from tandem integration of the expression cassettes at
a common genomic locus, an outcome favoured by co-transfection
[48–51]. Genomic proximity is known to enhance coordinated
expression [52,53], which is mediated, for example, by local
chromatin folding. The vectors also share common regulatory
sequences such as transcription factor binding sites and untrans-
lated regions, which may likewise play a role in coordinated
expression, though others have shown that noise correlations are
greatly reduced in pairs of otherwise identical expression cassettes
integrated at discrete sites [30,37,38], suggesting genomic
proximity may be the more important factor.
Contribution of Cell Size and Cell Cycle to Expression
Level Variation
To characterize expression level variation in the clone we first
sought to examine the influence of non-uniform population
structure (cell size and cell cycle phase) that exists during
asynchronous growth (Fig. 2). By imaging flow cytometry, both
cell volume and fluorescence per unit volume (fluorescence
concentration) were approximately log-normally distributed and
varied respectively over a ,10-fold range (Fig. 2A). This
substantial cell-to-cell heterogeneity is well illustrated in the
images captured during analysis, which also show that fluores-
cence is uniformly dispersed within most cells (Fig. 2B). While total
fluorescence did depend in part on cell volume (not shown),
fluorescence concentration was independent of cell volume
(R
2=0.002) (Fig. 2A). Thus expression on a volume-corrected
basis was not, on average, biased to large or small cells.
Furthermore, substantial variation was still present in volume-
corrected fluorescence at all cell sizes suggesting factors other than
cell size are involved.
Along with cell size, the rate of gene expression could vary
during the cell cycle. We found, however, that position in the cell
cycle, as measured by DNA content in fixed cells, explained little
(,2%) of the variation in reporter fluorescence, once cell size had
been accounted for (estimated by forward scatter area, FSC-A)
(Fig. 2C). This was also true in live cells and when cell size was
estimated by imaging flow cytometry (not shown). A lack of cell
cycle dependency after correcting for cell size is consistent with at
least one prior report [54]. We note that the half lives of EGFP
and EYFP are in the order of 24 h [55], limiting their
responsiveness to fluctuations with timescales of less than one cell
generation (,15 h). But such dampening of high frequency noise
is desirable for screening purposes, and irrespective of whether
additional underlying cell cycle fluctuations exist, the variations we
do detect are largely independent of the cell cycle.
Measurement Noise and Dynamic Response of Sorted
Subpopulations
To estimate the relative contribution of measurement noise to
observed variation and to establish a timescale for expression
fluctuations we tested the dynamic response of subpopulations
isolated from the clone. The highest and lowest 5% of expressing
cells in the clone were sorted by FACS, along with a control
(Fig. 3A, B), and reanalyzed at several time points (Fig. 3C, D).
During the sort, the high and low sort gates represent the truncated
tails of the expression distribution in the clone (Fig. 3B). Both
measurement noise and cellular variation contribute to this
distribution. After sorting, we immediately reanalyzed samples of
the sorted cells. The distributions of the sorted subpopulations
became broader and shifted towards the mean of the control
(compared to the original sort gates), though they remained
distinctly separated (Fig. 3C, Day 0). The relative magnitude of
this shift corresponds to the percent measurement noise, in this case
,30% of total variation (see Methods for details). By comparison,
variation in uniform calibration beads was only about 1% of the
variation in the clone (CV
2(beads)/CV
2(5H6) <0.05
2/0.5
2=1%).
This suggests most measurement noise is associated specifically with
cell measurements, and probably reflects the non-uniform shape,
internal structure, and orientation of cells in the sample stream
during flow analysis. Furthermore, although measurement noise is
significant, the majority of variation (,70%) is of biological rather
than technical origin, confirming that intraclonal heterogeneity is
not simply a measurement artifact.
The persistence of cellular variation was determined by
reculturing the sorted subpopulations in the presence of selection.
Over about 30 days, the original distribution was progressively
reestablished in both high and low subpopulations (Fig. 3C, Day
5–32). Thus, cellular variation in the clone is predominantly non-
heritable and reverts to a characteristic steady state. Cell size was
not a major contributing factor as median FSC-A showed no trend
with time and varied little across all sorted populations and time
points (mean square error 3%, not shown). The dynamics of
relaxation to steady state (Fig. 3D) were slow relative to the
population doubling time (,15 h), consistent with prior reports in
eukaryotes [39,56–58]. This ‘metastability’ seems to rule out
simple growth and division mechanisms, and suggests a degree of
mitotic inheritance or ‘cellular memory’. A longer timescale of
noise fluctuations (more technically, a longer autocorrelation) can
lead directly to a higher noise magnitude [59], which may explain
the occurrence of both a relatively long ‘mixing time’ and a high
CV in our system, compared to those observed by Sigal and co-
workers in human lung carcinoma cells [39]. Interestingly, we
found that the dynamic response to sort perturbations was
asymmetric, relaxing more quickly from high expression levels
(t1=2 =,5 generations) than from low expression levels (t1=2 =,11
generations) (Fig. 3D). This corresponds to mean transmitotic
(mother-daughter) correlations of 0.87 and 0.94, respectively [60].
The reason for asymmetric relaxation rates is not well understood
but has also been reported elsewhere [36,56] and is reminiscent of
negative feedback. Population dynamics could contribute to
asymmetry if growth rates are retarded at high expression levels
Clone Expression Heterogeneity
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sort eventually returns to the same steady state as the high sort,
albeit more slowly.
Dynamic Response of High-Expressing Subclones
Although the bulk of variation in the clone was non-heritable,
we sought to find out whether rare spontaneous variants possessing
heritable increases in expression could be isolated. We reasoned
this would require exceptionally high selection stringency given the
extent of background phenotypic variation and the presumed
genetic uniformity of the clone. By twice sorting the top 0.05% of
the population we obtained five subclones (including possible
siblings) with considerably higher fluorescence than the parental
clone, 5H6 (Fig. 4, 5). The final sort threshold was approximately
13-fold above the median fluorescence of the parental clone.
We then monitored the dynamic response of the subclones and the
parental clone during long-term culture in the presence of selection.
At the first timepoint (18 days after isolation), the median EGFP
fluorescence of the subclones was still approximately 7- to 11-fold
higher than the parental clone (Fig. 4B–F), a greater perturbation
than the earlier subpopulation sort (Fig. 3) due to the higher sort
stringency. Variation within each of the subclones (CV=0.5 to 0.7)
was already comparable to the parental clone (CV=0.5 at this
timepoint) and did not trend with time or expression level thereafter
(not shown). This suggests cells undergo rapid phenotypic diversifi-
cation but variation is constrained and reaches steady state.
Figure 2. Variation of expression with cell size and cell cycle. A) Fluorescence and cell volume measurements on live cells (Clone 5H6) by
imaging flow cytometry. Cell volume inferred by calculation from brightfield projected area (Methods). EGFP and EYFP fluorescence collected in a
single channel. Linear fit (red line) and R
2 are shown in main panel. Contours are percentiles (5%). Histogram counts on each axis are shown fitted to a
log-normal distribution (red curves). Fluorescence in arbitrary units (A.U.). B) Cell image field (montage) illustrating subset of events from (A) with
image centers aligned to match corresponding graph coordinates. False-color overlay of bright field and fluorescence channels. Scale bar, 20 mm.
Note: brightness is perceived per unit projected area, not per unit volume as plotted, making larger cells appear brighter in cross-section due to
depth of field. C) Fixed cells (Clone 5H6) stained with propidium iodide for DNA content and measured by conventional flow cytometry. EGFP
fluorescence corrected for cell volume (estimated by FSC-A, see Methods). EYFP similar (not shown). Linear fit (red line) and R
2 are shown in main
panel. Contours are percentiles (5%). Histogram counts on upper axis indicate cell cycle phases (G0/G1, S, G2/M). Fluorescence in arbitrary units (A.U.).
doi:10.1371/journal.pone.0008432.g002
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decayed by several fold. The kinetics were similar to the previous
subpopulation sort (Fig. 3)( t1=2 =,2–7 generations) suggesting a
common mechanism. Overall it took about 30–50 days for
expression levels in the subclones to stabilize (Fig. 4B–F). The
declines were similar in both magnitude and duration to those
normally seen during recombinant cell line development
[4,23,24,51], yet no underlying instability was observed in the
fluorescence of the parental clone, which remained constant over
the same time period (Fig. 4A). This is evidence that displacement
from steady state can contribute to a perceived lack of stability,
something not previously considered.
The steady state fluorescence reached in the subclones was
about 2.5- to 4-fold above that in the parental clone, implying that
the subclones did indeed possess heritable increases in expression.
Notably, however, the transient decay in fluorescence was larger
than the eventual differences in steady states, again underscoring
the relative dominance of non-heritable variation.
We used secretion assays at the population, colony, and single
cell level to confirm higher plateau expression in the subclones
(Fig. S2). Specific antibody secretion rates (pg/cell-day) measured
by ELISA obeyed similar kinetics to intracellular fluorescence, but
the relative increases over the parental clone were smaller,
particularly in subclones 5H6-GC7 and 5H6-GF10, whose
secretion rates changed only slightly despite large changes in
reporter fluorescence (Fig. 4C, E). This suggests transcriptional
increases are not fully passed on to secretion, consistent with
several prior reports [51,62–64]. In circumstances where only
Figure 3. Measurement noise and dynamic response of sorted subpopulations. A) High (red) and low (blue) subpopulations (top and
bottom 5% of expressing cells, respectively) were sorted from the clone (5H6) by FACS along with a control population (gray, all expressing cells,
including high and low). Fluorescence in arbitrary units (A.U.). B,C) EGFP fluorescence distributions of sorted subpopulations were monitored over
time (in the presence of selection). Average deviations due to cell variation ( e ec) and measurement noise ( e em) in the high subpopulation are indicated
by red and black arrows, respectively. Measurement noise was estimated to be ,30% of total variation (Methods). The low subpopulation and EYFP
channel yielded similar estimates (not shown). Data is from two independent sorting runs. Fluorescence in arbitrary units (A.U.). D) Median
fluorescence for each subpopulation was normalized to the control and plotted as a function of time (open circles). Relaxation half times (t1=2) were
estimated by fitting a first order exponential decay (lines). t1=2 (high sort)=3 days (,5 generations); t1=2 (low sort)=7 days (,11 generations). EYFP
similar (not shown).
doi:10.1371/journal.pone.0008432.g003
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PLoS ONE | www.plosone.org 5 December 2009 | Volume 4 | Issue 12 | e8432Figure 4. Dynamic response of high-expressing subclones. Five high-expressing subclones were isolated from parental clone 5H6 by
stringent FACS sorting. First, the top fluorescing 0.05% of the double-positive population was sorted and recultured for 10 days. Then the top 0.05%
of this enriched subpopulation was cloned by single cell deposition into a 96-well plate and the brightest five clonal colonies (5/26) were selected
(overall stringency roughly 1 in 20,000,000). A control 96-well plate sorted from the center of the double-positive population yielded 50 clonal
colonies, but none of comparable brightness to the selected subclones. Expression dynamics in the parental clone, A) and the five chosen subclones,
B–F), were monitored during long-term culture (in the presence of selection) by flow cytometry (median EGFP fluorescence, closed symbols) and
ELISA (cell specific antibody secretion rate, pg/cell-day, open symbols). Data is presented in terms of double positive cells, normalized to the parental
clone, and fitted to a first order exponential decay (lines). See Methods for details. Horizontal gray lines indicate the level of the parental clone
(normalized expression=1). Error bars are standard errors. t1=2 for subclones 5H6-GC2, -GC7, -GE5, -GF10, and -GG8 were 4 days (,4 generations), 6
days (,7 generations), 3 days (,4 generations), 7 days (,7 generations) and 2 days (,2 generations), respectively. EYFP similar (not shown).
doi:10.1371/journal.pone.0008432.g004
Figure 5. In-situ fluorescence and morphology of sorted subclones. Fluorescence and phase contrast images of the parental clone (5H6) and
subclones (5H6-GC2, -GC7, -GE5, -GF10, -GG8) in adherent culture 24 days after subcloning. Scale bars, 100 mm.
doi:10.1371/journal.pone.0008432.g005
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appear stable [16]. Additionally, our results demonstrate that the
severity of the secretion bottleneck can vary markedly, even
between closely-related subclones.
Subclones were also assessed for mean cell size, DNA index, and
doubling time. All subclones were DNA hyperdiploid with a larger
mean cell size than the parental clone, though cell volume alone
was not sufficient to account for expression increases (Table S1
and Fig. 4). On the other hand, larger mean cell size did coincide
with longer doubling times (Fig. S3) and altered culture
morphology (Fig. 5). Apparent doubling times also increased
during periods of higher expression in each subclone, but the
relationship was not as clear between subclones (Fig. S4).
Furthermore, although cells of similar fluorescence intensity
tended to be spatially clustered in culture (Fig. 5), no systematic
link to flask location or confluence was evident to implicate cell
microenvironment as the principal cause of expression heteroge-
neity. Instead, such clustering probably arose from the partial
mitotic inheritance of expression levels, as already described.
Lastly, the effect of intracellular pH variation and IRES-specific
regulation on reporter fluorescence are also possible considerations
(Text S1).
Discussion
When establishing stable cell lines, considerable variation is
observed between clones, which has traditionally been attributed
to genetic heterogeneity in the transfectant pools from which the
clones are isolated. We show that in addition to genetic
heterogeneity, a significant fraction of total variation may arise
from phenotypic differences between cells in each pure clone
making up a pool. This, in turn, appears to result from random
expression fluctuations in individual cells over time, as elegantly
demonstrated in the landmark study of Sigal et al. [39]. Since
phenotypic variation is ultimately non-heritable, the exploitable
diversity in transfectant pools may be less than previously thought.
The combination of novel intracellular transcription markers and
high-throughput single-cell analysis, along with the simplicity and
sensitivity of our method, was crucial to this advance.
Our results also raise the intriguing possibility that intraclonal
expression noise and positive selection bias may together
contribute to the apparent instability of freshly isolated clones.
Stable high producers are rare, and in the presence of sufficient
intraclonal variation, may be obscured by the upper tails of the
more abundant low producer population. These upper tails
represent the small fraction of low producers temporarily in a high
expression state due to expression variation. A stringent selection
threshold improves the likelihood of isolating true high producers
over background variation, but also more strongly biases for cells
perturbed above steady state at the time of selection. As we have
shown, if non-heritable variation is dominant, the downward
mean reversion may be more substantial than the ultimate
increase in steady state expression arising from stringent selection.
Selection bias may therefore be partly responsible for the
widespread belief that high producers are more unstable than
low producers [5]. We show that expression can equally increase
with time if the selection bias is negative, which may not have been
realized previously as low producers are rarely the target of
screening. This dissipation of non-heritable variation may thus
explain some anecdotal reports of clone rankings changing from
cloning through scale-up [65,66]. Rather than being unstable,
these clones may simply have not reached steady state. The
relative importance of this mechanism compared with more well-
established modes of expression instability [5], such as the
permanent loss or rearrangement of transgene copies, will depend
on the amplitude and persistence of expression fluctuations, which
are expected to be system-dependent. Thus, whether transient
effects are generally as significant as seen in this study remains to
be determined. We have, however, made similar observations with
other promoters such as the murine cytomegalovirus (mCMV)
promoter, suggesting this degree of variation is not strictly
promoter specific (unpublished data).
Expression noise is not limited to transgenes [38,39,57,58,67] or
transformed cells [36,68–74]. Indeed, it is becoming increasingly
evident that a wide repertoire of endogenous genes fluctuate
stochastically [29,36,72,73,75,76], particularly in culture [77],
resulting in an enormous diversity of physiological states, which
may also have an indirect effect on transgene expression. Non-
genetic variation enables cells to adapt to short-lived environmen-
tal changes without permanently accumulating potentially harmful
mutations [31,78]. Phenotypes must persist long enough for
survival of daughter cells but not so long that diversity cannot be
regenerated quickly. This intermediate timescale is consistent with
our present observations. For highly expressed proteins in
eukaryotes, stochasticity arises primarily from random bursts of
promoter activation [26,27,38,79–81] amplified by transcription
and translation [28,32,34], and turnover of mRNA and protein
[38,82]. Promoter activation seems to coincide with movement of
free chromatin loops in and out of ‘transcription factories’ [83].
Indeed, the presence of transcriptional bursting in CHO cells was
recently verified by Raj et al. [38], who employed fluorescence in-
situ hybridization to directly visualize single mRNA molecules
produced from an integrated reporter gene. Bursting, however,
typically involves timescales of minutes in prokaryotes and lower
eukaryotes [26,27,79] and hours in mammalian cells [38].
Furthermore, proteins are degraded and diluted by growth, with
a maximum half-life of about a cell generation. In order to achieve
the longer time constants we have observed, transitions must be
slower than this, perhaps in the order of days. Simply having less
frequent promoter bursts at a fixed low rate is expected to yield
expression distributions where many cells do not contain
detectable levels of the protein of interest [38,81,82]. Instead, to
give a realistic representation of our results, the rate constants
themselves must presumably undergo slow changes via additional
layers of extrinsic regulation [39], perhaps involving random low
frequency modulation of the underlying burst size or frequency. As
others have suggested, chromatin is one logical candidate to
mediate such regulation [30,32,38]. In fact, random fluctuations in
chromatin folding have previously been linked to fluctuations in
expression [84], and chromatin inheritance timescales are
consistent with those prevailing in our system [85]. It is also
possible, though we believe less likely, that gains and losses of
transgene copies or other factors such as genomic instability may
be involved in the dynamic and reversible shifts in expression level
we have observed. Moreover, although we have focused here on
graded fluctuations, binary switching between expressing and non-
expressing states are also possible [37,84]. The putative connection
with chromatin raises the fascinating prospect of a functional link
between expression noise and epigenetic gene silencing.
Predicting expression stability would be an important means to
accelerate cell line development. The fact that intraclonal
variation has not been widely recognized, and is apparently
probabilistic in nature, may explain why this has been difficult to
achieve. The precise molecular basis for random expression
fluctuations remains a matter for future research, but even if
epigenetic markers become available to predict stability, molecular
characterization of every clone is still likely to be too unwieldy for
routine screening. A simple alternative is to profile expression
Clone Expression Heterogeneity
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those which are most homogeneous [50,66]. A justification for this
approach is now clear in light of our results— clones with tight
distributions are more likely to be at or near steady state and to
experience only small transient adjustments in their median
expression level. Extending this principle, we predict that to
improve consistency and apparent stability across all clones, a
novel strategy would be to engineer reduced intraclonal expression
noise into the vector-host system. Low noise promoters [31,32,76],
noise-suppressing endogenous genes [32,86], favorable integration
sites [30,87], and recruitment of chromatin-opening or barrier
elements [88–90] are potentially promising avenues. Mechanisti-
cally, the most effective way to lower noise (CV) whilst maintaining
or increasing expression, is to reduce the ‘burstiness’ of promoter
activation, either by increasing the switching rate of promoter
states, increasing the fractional promoter ‘on’ time, or minimizing
pauses in elongation [29,32,40,91,92]. Alternatively, bursts may be
smoothed by adding independent or anticorrelated transgene
copies [33,38,91] in place of fully correlated copies that arise from
tandem integration and coamplification. In addition to noise
amplitude, we also envisage that noise kinetics could be
manipulated to facilitate clone screening, either to achieve steady
state more quickly for early comparison of clones, or to extend
transient dynamics so their effects are minimized during the
culture scale-up period.
Methods
Cell Lines and Cell Culture
CHO-K1 cells (ATCC CCL61) and derivative cell lines were
maintained in DMEM/F12 medium (Invitrogen) supplemented
with 10% fetal bovine serum (FBS) and 5 mM L-glutamine or
GlutamaxH (L-Ala-L-Gln dipeptide; Invitrogen) in tissue culture
treated plates or vent cap flasks in a humidified incubator at 37uC
and 5% CO2. Cells were subcultured every 3–4 days by rinsing
with Dulbecco’s phosphate buffered saline (DPBS), detaching with
TrypLE
TM (Invitrogen), and quenching with complete medium.
Cell counts were performed by haemocytometer or Cedex HiRes
(Innovatis).
Expression Vectors, Stable Transfection, Amplification,
and Cloning
The antibody expression vectors have been described previously
[44]. Briefly, the vector backbone [93] contains a neomycin
selection marker, full length human metallothionine IIA gene
(hMTIIA) as an amplifiable marker, and a metal-hyperinducible
promoter M2.6(D) derived from hMTIIA to drive transgene
expression [94]. See also Fig. 1A. The synthetic intron and
attenuated IRES originate from the pIRES series of vectors
(Clontech). Transfectants were generated by electroporation,
selection in 400 mg/ml G418, and amplification in metal up to
final concentrations of 100 mM ZnSO4 and 6 mM CdCl2,a s
described previously [44]. These G418 and metal concentrations
were then maintained continuously, providing sustained selection
pressure and promoter induction. Cloning was performed by
FACS single cell deposition into 96-well plates. Clonality was
assessed immediately after sorting by microscopic observation to
identify wells containing only a single cell.
Flow Cytometry and FACS
Analysis and sorting was performed on a BD FACSAria cell
sorter (Becton Dickinson) equipped with an automatic cell
deposition unit for sorting into plates. Cells were prepared by
mixing and straining through a 70 mm nylon mesh prior to
analysis or sorting. EGFP and EYFP were excited with a
13–20 mW CoherentH Sapphire
TM solid state laser at 488 nm,
and emissions collected with HQ510/20 BP and HQ550/30 BP
filters (Chroma). At least 10,000 events, and routinely 50,000
events, were acquired for each sample. Debris and doublets were
excluded by gating on forward scatter and side scatter dot plots
(FSC-A vs. SSC-A, FSC-W vs. FSC-H, SSC-W vs. SSC-H). Dead
cells were excluded by propidium iodide (2 mg/ml) and/or FSC
and SSC (back-gated from PI). Compensation for spectral overlap
and autofluorescence was performed each day using untransfected
and single-transfected control cell lines (Fig. 1B), and single-
stained untransfected cells. Automatic instrument compensation
was manually fine-tuned on split linear-log dot plots to match
median fluorescence values of negative and positive subpopula-
tions. Special care was taken to achieve precise compensation in
order to eliminate artificial correlations. Sphero 8-peak Rainbow
calibration beads (Spherotech) were used to set detector voltages
each day, standardize fluorescence measurements performed on
different days, and establish instrument resolution. All cell sorting
was performed with a 100 mm nozzle at 28 psig sheath pressure,
using the highest purity sort mask (single cell mode on the
FACSAria). Data was acquired with BD FACSDiva
TM software
(v5.0.1 or v6.0) and further analyzed with WEASEL v2.5 (Walter
and Eliza Hall Institute of Medical Research).
Imaging Flow Cytometry
An ImagestreamH 100 imaging flow cytometer (Amnis Corpo-
ration) was used to collect data for Fig. 2A, B. EGFP and EYFP
were excited with the 488 nm laser and fluorescence emissions
were collected together in the 500–560 nm channel. Brightfield,
darkfield, and fluorescence images were captured for each event.
Image analysis was carried out with Amnis IDEASH software
(v3.0), using default preprocessing settings. Fluorescence compen-
sation was performed using the built-in algorithm in best-fit mode,
and fine-tuned manually. Cell doublets and clumps were excluded
using various shape features calculated from the brightfield images
(area, aspect ratio, circularity, compactness, perimeter, and shape
ratio). Unfocused cells were gated out using contrast and gradient
RMS features in the brightfield channel. PI was used to
discriminate dead cells. The final gate, consisting of in-focus,
viable, reporter-positive single cells, comprised 1,171 events.
Cell Volume Estimation and Forward Scatter Correction
Cell volume was estimated from projected area measured by
imaging flow cytometry. Specifically, the default brightfield
segmentation mask was eroded by 3 pixels to give a closer fit to
the cell, and area (A) was determined by summing pixels in the
mask (each pixel 0.25 mm
2). Volume (V) was then calculated from
area-equivalent diameter, according to V=4/3p(A/p)
3/2. This
assumes cells are spherical, leading to slight overestimation of true
volume if cells deviate from perfect sphericity. For our needs the
estimates were adequate, particularly since projected cell images
(Fig. 2B) exhibited consistently high circularity. To account for
cell size in conventional flow cytometric analyses where images
were unavailable, we used forward scatter area (FSC-A) as a
surrogate for cell volume (Fig. 2C). Fluorescence was detrended
from FSC-A by linear regression. Residuals from the fit were
added to median fluorescence, effectively removing the correlation
with FSC-A.
Cell Cycle Analysis
Cell cycle analysis was performed on a BD LSR II flow
cytometer. Cell preparation steps were performed on ice and
designed to maximize retention of intracellular fluorescence. Cells
Clone Expression Heterogeneity
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incubated overnight in PBS with 250 mg/ml RNAse and
2.5 mg/ml PI, prior to analysis.
Measurement Noise Estimation
We used a variance component model to extract measurement
noise estimates from fluorescence distributions collected during and
immediately after cell sorting. Single cell fluorescence (x)( i ne i t h e r
EGFP or EYFP channels) was modeled by x~ x xzeczem,w h e r e
 x x is the ensemble average fluorescence, ec is the deviation in
fluorescence of a given cell due to cellular variation, and em is the
deviation in fluorescence of a given cell due to measurement noise
(all variables log-transformed). The (log-transformed) deviations
were assumed to be normally distributed (consistent with experi-
mental observations), with zero mean and variance proportional to
each noise source, i.e. ec*N 0,Var ec ðÞ ðÞ and em*N 0,Var) em ðÞ ðÞ .
According to this model, the overall mean deviation or bias in the
gated subpopulation during sorting is  e ecz e em,w h e r e e ec and  e em are
the average deviations due to cellular variation and measurement
noise, respectively (Fig. 3B). The same cells reanalyzed immediately
after sorting were assumed to be unchanged by the process of sorting
and the brief time elapsed, with  e ec retaining the same bias.
Conversely, the new measurement was independent of the first,
regenerating a full and unbiased measurement error distribution,
with  e em~0 (Fig. 3C, Day 0). From the two measurements,  e ec and
 e em in the sort gate are easily determined:  e ec is the average deviation
of the sorted cells in the reanalysis, and  e em is the difference between
the average deviation of sorted cells in the sort gate ( e ecz e em) and the
reanalysis ( e ec). The ratio of measurement bias to total bias in the sort
gate ( e em=  e ecz e em ðÞ ) is then equal to the ratio of measurement
variance to total variance (Var em ðÞ = Var ec ðÞ zVar em ðÞ ðÞ ), a rela-
tionship we verified by Monte-Carlo simulation. This ratio, when
expressed as a percentage, is the percent measurement noise. We
found photobleaching to be insignificant as low and high sorts
yielded similar estimates of measurement noise, supporting the
assumption of no change in underlying cell fluorescence between
measurements. Missorted cells, which have no effective sorting bias,
comprised a few percent of sorted cells, and appeared as a minor
secondary peak centered on  x x, but had little effect on the
measurement noise estimates.
Antibody ELISA
Culture supernatants were removed at each timepoint and stored
at 270uC. ELISA was performed as previously described [44].
Specific antibody secretion rates were calculated from endpoint
ELISA measurements and cell counts by dividing final antibody
yields by log-mean cell number and time elapsed in culture.
Standard errors were calculated using an error model accounting
for absolute and proportional error sources, along with well-to-well,
plate-to-plate, and day-to-day variability in ELISA measurements.
Data Normalization
Data were normalized for comparison purposes and to correct
for day-to-day variability. Fluorescence, in particular, must be
standardized for presentation of timecourse data (as units are
arbitrary). For sorted subpopulations and subclones, fluorescence
at each timepoint was divided by median fluorescence of the
parental clone (5H6) at the corresponding timepoint. For the
parental clone, fluorescence at each timepoint was normalized to
calibration beads, and then divided by the mean bead-normalized
fluorescence across all timepoints. Normalization was slightly
different for ELISA measurements as these were performed
together on retained samples, whereas fluorescence measurements
were performed independently at each timepoint. ELISA data was
normalized by dividing specific antibody secretion rates for each
timepoint by the mean specific antibody secretion rate of the
parental clone across all timepoints. Systematic variation in
measurement of secretion rate at particular timepoints was offset
by subtracting the residual between the parental clone at the
corresponding timepoint and its mean. To account for non-
expressing cells, both fluorescence and ELISA data were
calculated in terms of double-positive cells, which were generally
$98% of the population in the subclones, but comprised lower
percentages in the parental clone (after .100 days in culture).
Specifically, median fluorescence was calculated from gated
double-positive cells, and antibody secretion rates were divided
by the fraction of double-positive cells in the population. Cells
expressing only light or heavy chain gave no detectable ELISA
signal (data not shown).
Positive Expression Threshold
The threshold for positive expression was set manually based on
the distinct separation of subpopulations on a bivariate dot plot,
using untransfected and single-transfected controls as a guide.
Cells positive in both EGFP and EYFP fluorescence channels were
considered double-positive (‘expressing’) cells. Median fluores-
cence and the fraction of double-positive cells was not sensitive to
precise positioning of the threshold.
Fitting Relaxation Kinetics
First order exponential decays in Fig. 3D and Fig. 4 were fitted
based on three model parameters: initial level (t=0), steady state
level (tR‘), and half-time (t1/2). The fits were performed by
minimizing mean square error. For fluorescence data, all three
parameters were varied. For ELISA data, high scatter relative to
signal levels prevented reliable fitting with three parameters.
Instead, half-time was set to the value determined for the
corresponding fluorescence data, and the remaining two param-
eters were fit. The assumption of identical kinetics was reasonable
based on inspection of the fitted curves (Fig. 4). Half-times in
Fig. 3D were converted to approximate cell generations by
assuming a constant cell generation time of 15.3 h, based on
population growth data. For the subclones in Fig. 4, apparent
growth rates varied during the experiment (Fig. S4). To address
this, cumulative population doublings were calculated from cell
yields and inoculation densities at each passage, and curves were
independently fit against population doublings to obtain approx-
imate half-times in cell generations.
Fluorescence Microscopy
Images were captured on an Olympus CKX41 inverted
microscope with 50W mercury lamp, U-RFLT50-200 power
supply, DM500 dichroic mirror, BA520 IF barrier filter, and
BP460-490C excitation filter for EGFP and EYFP fluorescence,
using a MicroPublisher 3.3 RTV 10 bit color digital CCD camera
and Qcapture Pro 6.0 software (QImaging).
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